Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Encision's ebitda for the twelve months ending Sep 30, 2025 was -$232.24K. For fiscal 2025 it was -$90.59K. The highest annual figure on record is $598.73K in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$90.59K | – |
| FY2024 | Mar 31, 2024 | -$555.57K | – |
| FY2023 | Mar 31, 2023 | -$215.89K | – |
| FY2022 | Mar 31, 2022 | -$481.46K | -1862.7% |
| FY2021 | Mar 31, 2021 | $27.31K | – |
| FY2020 | Mar 31, 2020 | -$18.55K | – |
| FY2019 | Mar 31, 2019 | -$4.29K | -100.7% |
| FY2018 | Mar 31, 2018 | $598.73K | – |
| FY2017 | Mar 31, 2017 | -$463.37K | – |
| FY2016 | Mar 31, 2016 | -$389.67K | – |
| FY2015 | Mar 31, 2015 | -$802.43K | – |
| FY2014 | Mar 31, 2014 | -$1.01M | – |
| FY2013 | Mar 31, 2013 | -$231.22K | – |
| FY2012 | Mar 31, 2012 | -$209.61K | -167.5% |
| FY2011 | Mar 31, 2011 | $310.59K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$232.70K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $3.00K | -93.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.00K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$5.54K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$135.72K | -592.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $47.67K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$308.67K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$168.82K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $27.56K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$105.64K | -136.8% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$57.05K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$188.67K | -1276.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$257.16K | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $286.99K | +1223.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$375.38K | -315.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $16.04K | -51.9% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$143.81K | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $21.68K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $174.15K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $33.32K | -71.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$52.23K | -172.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$123.68K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$72.19K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $117.87K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $72.22K | -15.1% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$136.45K | -258.7% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$139.68K | -401.7% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$35.66K | -129.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $85.06K | -52.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $85.99K | -65.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $46.30K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $122.96K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $180.31K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $249.16K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$45.06K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$206.00K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$187.22K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$25.09K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$192.53K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$64.31K | – |
See a number that looks wrong?